Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies
- PMID: 7666535
- PMCID: PMC189533
- DOI: 10.1128/JVI.69.10.6342-6351.1995
Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies
Abstract
The aim of the study was to investigate the influence of V3 loops from naturally occurring viruses on the neutralization sensitivity of a molecularly cloned virus. A selection of well-defined syncytium-inducing (SI) and non-SI V3 loops of a single human immunodeficiency virus type 1-infected individual (H594) and the V3 regions of two SI laboratory strains were inserted in an infectious molecular clone of human immunodeficiency type 1 LAI. Neutralization was performed with a heterologous serum pool and autologous patient serum, using the virus reduction neutralization assay and peripheral blood lymphocytes as target cells. High sensitivity of the chimeric viruses containing the laboratory strain V3 regions to neutralization by H594 sequential sera as well as the heterologous serum pool was found. A statistically significant correlation between the sensitivities of these viruses was seen. In contrast, insertion of the primary isolate NSI and SI envelope V3 loops significantly reduced the neutralization by autologous serum but not by the heterologous serum pool. No correlation was found between the neutralization of the viruses with laboratory strain-derived V3 regions and the viruses with primary isolate V3 domains. We conclude that heterologous antibodies are able to neutralize infectious molecular clones with V3 loops of both SI and NSI viruses, regardless of whether they originated from laboratory strains or primary isolates. However, serum of patient H594 discriminated between the two types of viruses and showed reduced neutralization of the viruses with the autologous NSI and SI primary isolate V3 loops. These results indicated that the neutralization sensitivity of the viruses depended on the capacity of the V3 region to influence the conformation of the virus envelope. These V3-dependent conformational changes partially explain the neutralization sensitivity of laboratory strains and the relative neutralization resistance of primary isolates.
Similar articles
-
Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum.J Virol. 1994 Jun;68(6):3908-16. doi: 10.1128/JVI.68.6.3908-3916.1994. J Virol. 1994. PMID: 8189527 Free PMC article.
-
Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.J Virol. 1995 Nov;69(11):7099-105. doi: 10.1128/JVI.69.11.7099-7105.1995. J Virol. 1995. PMID: 7474129 Free PMC article.
-
A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response.J Virol. 2002 Jan;76(2):644-55. doi: 10.1128/jvi.76.2.644-655.2002. J Virol. 2002. PMID: 11752155 Free PMC article.
-
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).AIDS Res Hum Retroviruses. 1994 Sep;10(9):1143-55. doi: 10.1089/aid.1994.10.1143. AIDS Res Hum Retroviruses. 1994. PMID: 7826699
-
Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence.Curr Top Microbiol Immunol. 1994;188:185-219. doi: 10.1007/978-3-642-78536-8_11. Curr Top Microbiol Immunol. 1994. PMID: 7523031 Review.
Cited by
-
Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count.Clin Diagn Lab Immunol. 2000 May;7(3):412-6. doi: 10.1128/CDLI.7.3.412-416.2000. Clin Diagn Lab Immunol. 2000. PMID: 10799454 Free PMC article.
-
Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo.J Virol. 2000 Dec;74(24):11955-62. doi: 10.1128/jvi.74.24.11955-11962.2000. J Virol. 2000. PMID: 11090196 Free PMC article.
-
Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.J Virol. 1998 Sep;72(9):6988-96. doi: 10.1128/JVI.72.9.6988-6996.1998. J Virol. 1998. PMID: 9696790 Free PMC article.
-
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.J Virol. 2002 Sep;76(18):9035-45. doi: 10.1128/jvi.76.18.9035-9045.2002. J Virol. 2002. PMID: 12186887 Free PMC article.
-
Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.J Virol. 2001 Apr;75(8):3903-15. doi: 10.1128/JVI.75.8.3903-3915.2001. J Virol. 2001. PMID: 11264379 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources